Literature DB >> 6427040

Localization of aldose reductase in the human eye.

Y Akagi, Y Yajima, P F Kador, T Kuwabara, J H Kinoshita.   

Abstract

The presence of the enzyme aldose reductase is increasingly being linked to diabetic complications. The distribution of this enzyme in human cornea, lens, retina, and optic nerve has been studied using specific antibodies against purified human placental aldose reductase raised in both rabbit and goat. The antisera from both animals gave equal, specific reactions. In frozen sections of ocular tissues, significant aldose reductase localization was reproducibly demonstrated in the endothelium and epithelium of the cornea and in the basal cell layers of the conjunctiva. In the lens, staining was observed in the epithelium and superficial lens fibers. In retinal sections, the presence of aldose reductase was demonstrated in the Mueller's cells, especially near the inner limiting membrane. It was also found in some ganglion and cone cells. In the optic nerve, positive staining was observed in the axon. All other cells of the tissues examined revealed only weak, nonspecific staining.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6427040     DOI: 10.2337/diab.33.6.562

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  30 in total

1.  Osmotic stress, not aldose reductase activity, directly induces growth factors and MAPK signaling changes during sugar cataract formation.

Authors:  Peng Zhang; Kuiyi Xing; James Randazzo; Karen Blessing; Marjorie F Lou; Peter F Kador
Journal:  Exp Eye Res       Date:  2012-06-15       Impact factor: 3.467

Review 2.  Understanding the role of aldose reductase in ocular inflammation.

Authors:  U C S Yadav; S K Srivastava; K V Ramana
Journal:  Curr Mol Med       Date:  2010-08       Impact factor: 2.222

3.  Prevention of diabetic keratopathy.

Authors:  Y Kaji
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

4.  Metabolism of the aldose reductase inhibitor ALO1567 in man.

Authors:  Y H Park; J E Hudson; R C Barker; B M York; R K Brazzell
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

5.  A randomised, placebo controlled clinical trial of the aldose reductase inhibitor CT-112 as management of corneal epithelial disorders in diabetic patients.

Authors:  M Nakahara; K Miyata; S Otani; T Miyai; R Nejima; S Yamagami; S Amano
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

6.  A non-healing corneal ulcer as the presenting feature of type 1 diabetes mellitus: a case report.

Authors:  Alexander S Ioannidis; Sofia L Zagora; Alfred W Wechsler
Journal:  J Med Case Rep       Date:  2011-11-04

Review 7.  The role of endothelium in the pathogenesis of diabetic microangiopathy.

Authors:  M La Selva; E Beltramo; P Passera; M Porta; G M Molinatti
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

8.  Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA.

Authors:  T Yamaoka; C Nishimura; K Yamashita; M Itakura; T Yamada; J Fujimoto; Y Kokai
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

9.  Aldo-keto reductases in the eye.

Authors:  Shun Ping Huang; Suryanarayana Palla; Philip Ruzycki; Ross Arjun Varma; Theresa Harter; G Bhanuprakesh Reddy; J Mark Petrash
Journal:  J Ophthalmol       Date:  2010-06-13       Impact factor: 1.909

10.  Sorbitol metabolism in retina studied in vitro.

Authors:  P Naeser; S E Brolin; U J Eriksson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.